Drug use in pregnancy-physicians' evaluation of quality and clinical impact of drug information centres

European Journal of Clinical Pharmacology

Volumn 65, Issue 3, 2009, Pages 303-308

  Frost Widnes, Sofia Kristina ^a   Schjøtt, Jan ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Drug information centres; Evaluation; Physicians; Pregnancy; Quality

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DRUG INFORMATION; DRUG USE; GENERAL PRACTITIONER; HUMAN; INDUCED ABORTION; INFORMATION CENTER; NORWAY; PATIENT COUNSELING; PHYSICIAN; PREGNANCY; PREGNANCY TERMINATION; PREGNANT WOMAN; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; RISK REDUCTION; TERATOGENICITY;

DRUG INFORMATION SERVICES; FEMALE; HUMANS; NORWAY; PHARMACEUTICAL PREPARATIONS; PHYSICIANS; PREGNANCY; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 60549088504     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-008-0593-4     Document Type: Article

References (30)

1. J Goodwin S Rieder MJ Rieder 2007 Counseling regarding pregnancy-related drug exposures by family physicians in Ontario Can J Clin Pharmacol 14 e58 e69
2. A Raal K Fischer A Irs 2006 Determination of drug information needs of health care professionals in Estonia Medicina (Kaunas) 42 1030 1034
3. M McMullan 2006 Patients using the Internet to obtain health information: how this affects the patient-health professional relationship Patient Educ Couns 63 24 28
4. HS Wald CE Dube DC Anthony 2007 Untangling the Web-the impact of Internet use on health care and the physician-patient relationship Patient Educ Couns 68 218 224
5. M Nylenna OG Aasland 2000 Primary care physicians and their information-seeking behaviour Scand J Prim Health Care 18 9 13
6. PJ Gjersvik M Nylenna OG Aasland 2001 How do Norwegian dermatologists keep themselves professionally updated Tidsskr Nor Laegeforen 121 3515 3518
7. SKF Widnes J Schjøtt 2008 Advice on drug safety in pregnancy-are there differences between common sources of information Drug Saf 31 799 806
8. A Engeland JG Bramness AK Daltveit 2008 Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006 Br J Clin Pharmacol 65 653 660
9. RL Hancock G Koren A Einarson 2007 The effectiveness of Teratology Information Services (TIS) Reprod Toxicol 23 125 132
10. A Einarson A Park G Koren 2004 How physicians perceive and utilize information from a teratogen information service: the Motherisk Program BMC Med Educ 4 6
11. AA Cardoni TJ Thompson 1978 Impact of drug information services on patient care Am J Hosp Pharm 35 1233 1237
12. J Schjott E Pomp A Gedde-Dahl 2002 Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians Eur J Clin Pharmacol 57 897 902
13. T Bertsche A Hammerlein M Schulz 2007 German national drug information service: user satisfaction and potential positive patient outcomes Pharm World Sci 29 167 172
14. PS Melnyk YM Shevchuk AJ Remillard 2000 Impact of the dial access drug information service on patient outcome Ann Pharmacother 34 585 592
15. RP Baker GR Gallo 1984 Drug information services: how health care professionals use the information provided J Clin Hosp Pharm 9 133 138
16. LK Golightly AG Davis WJ Budwitz 1988 Documenting the activity and effectiveness of a regional drug information center Am J Hosp Pharm 45 356 361
17. M Clementi E Di Gianantonio A Ornoy 2002 Teratology information services in Europe and their contribution to the prevention of congenital anomalies Community Genet 5 8 12
18. G Koren M Bologa D Long 1989 Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester Am J Obstet Gynecol 160 1190 1194
19. G Koren A Pastuszak 1990 Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester Teratology 41 657 661
20. E Sanz T Gomez-Lopez MJ Martinez-Quintas 2001 Perception of teratogenic risk of common medicines Eur J Obstet Gynecol Reprod Biol 95 127 131
21. M Pole A Einarson N Pairaudeau 2000 Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals J Clin Pharmacol 40 573 577
22. P McGettigan J Golden J Fryer 2001 Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message Br J Clin Pharmacol 51 184 189
23. H Prosser S Almond T Walley 2003 Influences on GPs' decision to prescribe new drugs-the importance of who says what Fam Pract 20 61 68
24. C Furtado JA Pereira 2006 [Information sources and prescribing in the Lisbon region] Acta Med Port 19 301 308
25. C Ljungberg AK Lindblad MP Tully 2007 Hospital doctors' views of factors influencing their prescribing J Eval Clin Pract 13 765 771
26. MR Layton W Sritanyarat S Chadbunchachai 2007 Sources of information for new drugs among physicians in Thailand Pharm World Sci 29 619 627
27. J Straand IJ Christensen 2008 Quality of pharma rep meetings in general practice Tidsskr Nor Laegeforen 128 555 557
28. CA Gaither RP Bagozzi FJ Ascione 1997 The determinants of physician attitudes and subjective norms toward drug information sources: modification and test of the theory of reasoned action Pharm Res 14 1298 1308
29. MY Peay ER Peay 1990 Patterns of preference for information sources in the adoption of new drugs by specialists Soc Sci Med 31 467 476
30. MY Peay ER Peay 1984 Differences among practitioners in patterns of preference for information sources in the adoption of new drugs Soc Sci Med 18 1019 1025